GlassScriptPhysician profile
Sami Nasrallah
NPI 1255528600
$1,086.36
in general payments reported to CMS, 2019-2025
14 companies · $454 in 2025
The $454 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.41 · 2023: $276 · 2024: $340 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.68 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $250.35 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Travere Therapeutics, INC. | $161.51 | 2023 | |
| Dexcom, INC. | $147.34 | 2024-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $119.05 | 2025 | |
| Amgen INC. | $69.19 | 2024-2025 | Evenity, Prolia, Prolia |
| Recordati_rare_diseases_inc. | $62.87 | 2025 | Isturisa |
| Xeris Pharmaceuticals, INC. | $57.89 | 2024-2025 | Recorlev |
| Beta Bionics, INC. | $51.01 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Corcept Therapeutics | $47.74 | 2025 | Korlym |
| Ascendis Pharma Endocrinology INC | $44.12 | 2025 | Yorvipath |
| Medtronic, INC. | $20.90 | 2024 | Minimed 780g |
| Mannkind Corporation | $20.53 | 2024 | |
| Insulet Corporation | $17.45 | 2024 | Omnipod |
| Boston Scientific Corporation | $16.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Nasrallah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.